SCHEMBL1046368

SCHEMBL1046368

C[C@H](N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209653 1.00
SCHEMBL4536370 1.00
Iodide SCHEMBL23540723 0.96
Hydrochloric Acid SCHEMBL4239509 0.96
SCHEMBL3565343 0.80 SLC1A3 (0.33)
SCHEMBL18883028 0.78
Isopropylamine SCHEMBL10634731 0.73
Isobutyraldehyde SCHEMBL6841306 0.73
SCHEMBL16548260 0.72
SCHEMBL7029259 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3836971-A1 CONJUGATES AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2021-06-23 EP claimed
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-06-03 US claimed
WO-2020037009-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2020-02-20 WO claimed
EP-2809647-B1 MGLU 2/3 AGONISTS LILLY CO ELI (US) 2016-07-06 EP claimed
EP-2721012-B1 BICYCLO(3.1.0)HEXANE-2,6-DICARBOXYLIC ACID DERIVATIVES AS MGLU2 RECEPTOR AGONIST LILLY CO ELI (US) 2016-05-25 EP claimed
US-9296710-B2 Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist ELI LILLY AND COMPANY (US) 2016-03-29 US claimed
CN-103596933-B As dicyclo (3.1.0) hexane-2, the 6-dicarboxylic acid derivatives of MGLU2 receptor stimulant ELI LILLY AND CO. (US) 2016-03-23 CN claimed
CN-104093703-B Mglu 2/3 agonist ELI LILLY AND CO. (US) 2016-01-20 CN claimed
CN-102898330-B Colchicine derivatives UNIV ZHEJIANG 2015-02-25 CN claimed
CN-104230937-A Colchicine derivative UNIV ZHEJIANG 2014-12-24 CN claimed
CN-1041919-C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists FUJISAWA PHARMACEUTICAL CO (JP) 1999-02-03 CN claimed
EP-0869944-A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-10-14 EP claimed
WO-1996029309-A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-09-26 WO claimed
CN-1116847-A N- (3-piperidinylcarbonyl) -beta-aminopropionic acid derivatives as PAF antagonists FUJISAWA PHARMACEUTICAL CO (JP) 1996-02-14 CN claimed
EP-0669912-A1 N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-09-06 EP claimed
WO-1995008536-A1 N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-03-30 WO claimed
EP-0413209-A1 LHRH analogs TAP Pharmaceuticals Inc. (US) 1991-02-20 EP claimed
EP-0114091-B1 COATING COMPOSITION COMPRISING BIS-DIENE OLIGOMERS AND BIS-DIENEOPHILE OLIGOMERS FORD MOTOR COMPANY LIMITED (GB) 1986-11-05 EP claimed
US-4515926-A Coating composition comprising bis-diene oligomers and bis-dieneophile oligomers FORD MOTOR COMPANY (US) 1985-05-07 US claimed
EP-0114091-A1 Coating composition comprising bis-diene oligomers and bis-dieneophile oligomers FORD MOTOR COMPANY LIMITED (GB) 1984-07-25 EP claimed